Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression.

Douglas D, Hsu JH, Hung L, Cooper A, Abdueva D, van Doorninck J, Peng G, Shimada H, Triche TJ, Lawlor ER.

Cancer Res. 2008 Aug 15;68(16):6507-15. doi: 10.1158/0008-5472.CAN-07-6152.

2.

Ewing sarcoma family of tumors.

Khoury JD.

Adv Anat Pathol. 2005 Jul;12(4):212-20. Review.

PMID:
16096383
3.

Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.

Cope JU, Reaman GH, Tonning JM.

Sarcoma. 2015;2015:948159. doi: 10.1155/2015/948159. Review.

Supplemental Content

Support Center